 The mini-invasive device Glucoday should provide real-time glucose concentrations in order to quickly adjust insulin infusion rates. The objective of MARGE study is to compare percent of time in normoglycemia based on conventional monitoring discontinuous glucose monitoring and Glucoday to conventional monitoring alone. The MARGE study is a multicenter 2 centers, randomized, single blind trial. 